Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?
- Autores
- Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins.
Fil: Goffin, Vincent. Universite de Paris V; Francia. Inserm; Francia
Fil: Becu, Damasia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Popovic, Vera. University of Belgrade; Serbia
Fil: Grattan, David R.. University of Otago; Nueva Zelanda - Materia
-
PROLACTIN
METABOLISM
CANCER
ADIPOSE TISSUE
THERAPY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/243789
Ver los metadatos del registro completo
id |
CONICETDig_7e6bbabf5c7cd4156a364f7425fa116c |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/243789 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?Goffin, VincentBecu, DamasiaPopovic, VeraGrattan, David R.PROLACTINMETABOLISMCANCERADIPOSE TISSUETHERAPYhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins.Fil: Goffin, Vincent. Universite de Paris V; Francia. Inserm; FranciaFil: Becu, Damasia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Popovic, Vera. University of Belgrade; SerbiaFil: Grattan, David R.. University of Otago; Nueva ZelandaFrontiers Media2023-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/243789Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.; Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?; Frontiers Media; Frontiers in Endocrinology; 14; 6-2023; 1-21664-2392CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1213895/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fendo.2023.1213895info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:42:08Zoai:ri.conicet.gov.ar:11336/243789instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:42:08.477CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
title |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
spellingShingle |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? Goffin, Vincent PROLACTIN METABOLISM CANCER ADIPOSE TISSUE THERAPY |
title_short |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
title_full |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
title_fullStr |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
title_full_unstemmed |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
title_sort |
Towards targeting prolactin signaling in human diseases: Stimulate or inhibit? |
dc.creator.none.fl_str_mv |
Goffin, Vincent Becu, Damasia Popovic, Vera Grattan, David R. |
author |
Goffin, Vincent |
author_facet |
Goffin, Vincent Becu, Damasia Popovic, Vera Grattan, David R. |
author_role |
author |
author2 |
Becu, Damasia Popovic, Vera Grattan, David R. |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
PROLACTIN METABOLISM CANCER ADIPOSE TISSUE THERAPY |
topic |
PROLACTIN METABOLISM CANCER ADIPOSE TISSUE THERAPY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins. Fil: Goffin, Vincent. Universite de Paris V; Francia. Inserm; Francia Fil: Becu, Damasia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Popovic, Vera. University of Belgrade; Serbia Fil: Grattan, David R.. University of Otago; Nueva Zelanda |
description |
Prolactin is an anterior pituitary hormone that was originally named for its indispensable role in lactation, but increasingly it is being recognized for pleiotropic roles in metabolism, immune function, pregnancy adaptations and parental behaviour. Prolactin secretion is tightly controlled by a short-loop feedback system whereby prolactin stimulates specific neurons in the hypothalamus to release dopamine, which then inhibits prolactin secretion. During pregnancy and lactation, however, this feedback systems adapts to allow prolonged elevations in prolactin secretion, enabling a range of functions specific to these conditions. Prolactin is also released under conditions of stress in both sexes. Prolactin signals exclusively through the prolactin receptor (Prlr), but this is not a simple system. In target cells, prolactin/Prlr engages various signal transduction mechanisms including JAK2/STAT5 (canonical), PI3K/Akt, MAPK and Src family kinases. There is also evidence of local production of prolactin in non-pituitary tissues, leading to autocrine/paracrine receptor triggering independent of circulating hormone. Adding to this complexity, in many species, including humans, there are multiple ligands for the Prlr. These include placental lactogens that supplement prolactin function in pregnancy, and in primates only, pituitary growth hormone. Moreover, specific proteolytic products of these hormones exert important biological actions independent of Prlr. These functions, that are often completely distinct from those of prolactin, have led to the classification of these fragments as a new class of hormones known as vasoinhibins. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/243789 Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.; Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?; Frontiers Media; Frontiers in Endocrinology; 14; 6-2023; 1-2 1664-2392 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/243789 |
identifier_str_mv |
Goffin, Vincent; Becu, Damasia; Popovic, Vera; Grattan, David R.; Towards targeting prolactin signaling in human diseases: Stimulate or inhibit?; Frontiers Media; Frontiers in Endocrinology; 14; 6-2023; 1-2 1664-2392 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1213895/full info:eu-repo/semantics/altIdentifier/doi/10.3389/fendo.2023.1213895 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers Media |
publisher.none.fl_str_mv |
Frontiers Media |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614453640822784 |
score |
13.070432 |